Ibaraki, Japan

Osamu Takenaka

This inventor holds 1 USPTO granted patent. Top assignee: Eisai Company, Limited. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Osamu Takenaka. Retrieved from https://idiyas.com/inventor/osamu-takenaka-2230ula2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Osamu Takenaka - Innovator in Pharmaceutical Chemistry

Introduction

Osamu Takenaka is a prominent inventor based in Ibaraki, Japan, known for his contributions to the field of pharmaceutical chemistry. His innovative work has led to the patenting of significant compounds that potentially contribute to medical advancements.

Latest Patents

Takenaka holds a patent for Benzopiperidine derivatives, showcasing his expertise in developing novel chemical compounds. This patent represents a step forward in the exploration of new therapeutic agents.

Career Highlights

Osamu Takenaka is currently employed at Eisai Company, Limited, a leading global research and development-based pharmaceutical company. His role at Eisai allows him to utilize his inventive skills to drive forward-thinking solutions in medicine.

Collaborations

Throughout his career, Takenaka has collaborated with notable colleagues in the industry, including Toshihiko Kaneko and Richard S. Clark. These partnerships have fostered an environment of creativity and innovation, pushing the boundaries of pharmaceutical research.

Conclusion

In summary, Osamu Takenaka's contributions as an inventor in the pharmaceutical sector, along with his valuable collaborations, underscore his role in advancing innovations that may lead to significant medical breakthroughs. His work at Eisai Company, Limited highlights his commitment to enhancing healthcare through science and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…